Similarly, other comprehensive studies suggest that the combined analysis of the mutational status of TERT, IDH, and 1p/19q deletion had the ability to define the biological and clinical behavior of gliomas better than analysis based solely in histology (Foote et al. 2015; Eckel-Passow et al. 2015). This evidence concerns the gene IDH1 and central nervous system cancer.